Navigation Links
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
Date:5/15/2012

ns, SYNERGY and PROMUS Element stent systems performance and effects.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking stateme
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
5. New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease
6. Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
7. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
8. One-Year European Registry Data Released for Popliteal Stenting With SUPERA®
9. Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ... 225mg and 300mg oral tablets, indicated for use in ... for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was ... Arthur S. Przybyl , President and Chief Executive ... of our fourth product from the portfolio of approved ...
(Date:3/31/2015)... -- Biorasi , a full-service CRO powered ... Medidata , the leading global provider of ... Offering therapeutic expertise in a number of areas, ... capture (EDC), management and reporting system, Medidata Rave®, ... clinical trial business. ...
(Date:3/31/2015)... 31, 2015  Cindy Dellecker, former Senior Vice President of ... has accepted a position on the TruHearing Advisory Board. ... care to TruHearing and will act as an advisor ... "Hearing healthcare has always been an important ... personal level," said Dellecker.  "I,m excited to be on ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4TruHearing Announces Addition of Cindy Dellecker to Advisory Board 2
... YORK, March 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, ... China-based pharmaceutical company,dedicated to improving health through ... range of prescription and over the counter ... initiating a phase one clinical,trial of AOBO-001, ...
... Association (AMA) Foundation announced today the 28 recipients of the 2009 Seed ... to medical students, physician residents and fellows to conduct basic science, applied ... in the following four categories: , , ... HIV/AIDS , ...
Cached Medicine Technology:American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule 2American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule 3AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3
(Date:3/31/2015)... Illinois (PRWEB) March 31, 2015 ... Visio Stencils Device Library for documenting and diagramming ... following Visio Stencils: , Manufacturer / Device ... PowerEdge r720, Dell PowerEdge r520, Dell PowerEdge r630, ... Power 8 Series, EMC VMAX 100K, VMAX 200K, ...
(Date:3/31/2015)... Indiana (PRWEB) March 31, 2015 ... DeRose in Youngstown, Ohio in 1987. This ... the curve with not just customer satisfaction, but ... been added to the well-stocked arsenal of Yesco ... by American Green Technology® (AGT). The patented environmental ...
(Date:3/31/2015)... 31, 2015 Burns Engineering announces 3-Day Quick ... for the Food & Beverage, Pharmaceutical and Biotech markets. These ... ASME-BPE compliant and are now available as part of Burns’ ... , The S01 and S03 with 1/8” and ... process connections used in process lines 1/4” and larger. ...
(Date:3/31/2015)... 31, 2015 The Heart Fit ... Calgary and surrounding areas. External Counterpulsation is an ... artery disease, specifically stable coronary artery disease. ... is used extensively all over the world for ... Calgarians (Albertans) are extremely fortunate to have the ...
(Date:3/31/2015)... Orlando, FL (PRWEB) March 31, 2015 ... and Sickness Insurance programs, issues a travel advisory to ... Health care costs in the United States are higher ... than even in developed countries. For example, a ... while the same procedure costs about $34,358 . ...
Breaking Medicine News(10 mins):Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:American Green Technology® Signs Exclusive Agreement to Distribute Health Risk Management System in Midwest 2Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:New Heart Disease Treatment Called External Counterpulsation (EECP) helps people of Alberta Who Have Failed or Are Not Suitable For Heart Stents or Surgery 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3
... is in the process of doing away with a commonly ... phase out the ‘Aropax’ brand of paroxetine and bring in ... used by about 49,000 New Zealanders. ,This move ... maintains that both drugs are the same, except for the ...
... Forest University Baptist Medical Center are helping to lead ... that will test 3,000 patients in an effort to ... patients. ,Though doctors have promoted the value of ... training has not been definitively established as safe in ...
... why we shed tears. But exactly what our tears are made ... study sheds some light on the complex design of tears. What ... made up of three distinct, microscopic layers. The middle, watery layer ... – is sandwiched between a layer of mucus and an outer ...
... is an alarming rise of gambling and gamblers in Britain. ... gambling and casinos then on vegetables and fruits. ... been spent on gambling in United Kingdom. Online gambling has ... time. ,The British medical Association (BMA) has expressed ...
... The death of a 47-year-old man who had worked for ... hundreds of ex-employees, who had also been exposed to toxic ... Thursday, prompting more than 500 protestors, who said he had ... roads and demand an autopsy to assess the possibility of ...
... Plc, Europe's pharmaceutical giant, is finalizing its plan of action, ... Gardasil, in a bid to establish the most effective vaccine ... conducted in the United States, will seek to evaluate the ... to two strains of the human papillomavirus. This virus is ...
Cached Medicine News:Health News:New International Study to Test Exercise in Heart Failure Patients 2Health News:New International Study to Test Exercise in Heart Failure Patients 3Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 2Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 3Health News:Ex-workers Ask HLL to Accept Liability for Mercury Deaths 2
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband....
Headlight module is mounted on UltraLite Plus headband....
... rapid rise in intracranial ... intervention and continuous monitoring. ... technology that gets to ... Its versatility makes it ...
Medicine Products: